Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

Archives of General Psychiatry

Volumn 54, Issue 12, 1997, Pages 1073-1080

  Klein, Rachel G ^a,b   Abikoff, Howard ^a   Klass, Emily ^a   Ganeles, David ^a   Seese, Laura M ^a   Pollack, Simcha ^a,c  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADOLESCENT; AGGRESSION; ANTISOCIAL BEHAVIOR; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CHILD PSYCHIATRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; RATING SCALE; TREATMENT OUTCOME;

EID: 0030834395     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830240023003     Document Type: Article

References (59)

1. Rutter M, Shatter D. DSM-III: a step forward or back in terms of the classification of child psychiatric disorders? J Am Acad Child Psychiatry. 1980;19:371-394.
2. Sandberg ST. The overinclusiveness of the diagnosis of hyperkinetic syndrome. In: Gittelman M, ed. Strategic Interventions for Hyperactive Children. Armonk, NY: ME Sharpe; 1981:8-38.
3. Sandberg ST, Rutter M, Taylor E. Hyperkinetic disorder in psychiatric clinic attenders. Dev Med Child Neurol. 1978;20:279-299.
4. Sandberg ST, Wieselberg M, Shatter D. Hyperkinetic and conduct problem children in a primary school population: some epidemiological considerations. J Child Psychol Psychiatry. 1980;21:293-311.
5. Shatter D, Greenhill L. A critical note on the predictive validity of 'the hyperkinetic syndrome.' J Child Psychol Psychiatry. 1979;20:61-72.
6. Rutter M, Tizard J, Whitmore K. Education, Health and Behavior. Huntington, NY: Krieger Publishing Co; 1981.
7. Prendergast M, Taylor E, Rapoport JL, Bartko J, Donnelly M, Zametkin A, Ahearn MB, Dunn G, Wieselberg HM. The diagnosis of childhood hyperactivity: a U.S.- U.K. cross-national study of DSM-III and ICD-9. J Child Psychol Psychiatry. 1988; 29:289-300.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
11. Klein DF. The pharmacological validation of psychiatric diagnosis. In: Robins LN, Barrett J, eds. Validity of Psychiatric Diagnosis. New York, NY: Raven Press; 1989: 203-216.
12. Eisenberg L, Lachman R, Molling PA, Lockner A, Mizelle JD, Conners CK. A psychopharmacologic experiment in a training school for delinquent boys: methods, problems, findings. Am J Orthopsychiatry. 1963;33:431-447.
13. Maletsky BM. d-Amphetamineand delinquency: hyperkinesis persisting? Dis Nerv Syst 1974;35:543-547.
14. Conners CK, Kramer R, Rothschild GH, Schwartz L, Stone A. Treatment of young delinquent boys with diphenylhydantoin sodium and methylphenidate. Arch Gen Psychiatry. 1971;24:156-160.
15. Brown RT, Jaffe SL, Silverstein J, Magee H. Methylphenidate and adolescents hospitalized with conduct disorder: dose effects on classroom behavior, academic performance, and impulsivity. J Clin Child Psychol. 1991;20:282-292.
16. Sheldrick EC. Treatment of delinquents. In: Rutter M, Hersov L, eds. Child and Adolescent Psychiatry. 2nd ed. Boston, Mass: Blackwell Scientific Publications; 1985:743-752.
17. Earls F. Oppositional-defiant and conduct disorders. In: Rutter M, Taylor E, Hersov L, eds. Child and Adolescent Psychiatry: Modern Approaches. 3rd ed. Oxford, England: Blackwell Scientific Publications; 1994:308-329.
18. Maletic V, March JS, Johnston HF. Child and adolescent psychopharmacology. Psychiatr Clin North Am: Ann Drug Ther. 1994;1:101-124.
19. Wilens TE, Biederman J. The stimulants, in: Shaffer D, ed. Psychiatr Clin North Am. 1992;15:191-222.
20. Jacobvitz D, Sroufe LA, Steward M, Leffert N. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry. 1990;29:677-688.
21. Kaplan CA, Hussain S. Use of drugs in child and adolescent psychiatry. Br J Psychiatry. 1995;166:291-298.
22. O'Donnell DJ. Conduct disorders. In: Wiener JM, ed. Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders. New York, NY: Basic Books; 1985:249-287.
23. Werry J. Pharmacotherapy of disruptive behavior disorders. Child Adolesc Psychiatr Clin North Am. 1994;3:321-341.
24. Stoewe JK, Kruesi MJP, Lelio DF. Psychopharmacology of aggressive states and features of conduct disorder. In: Riddle MA, ed. Child Adolesc Psychiatr Clin North Am. 1995;4:359-379.
25. Hinshaw SP. Stimulant medication and the treatment of aggression in children with attentional deficits. J Clin Child Psychol. 1991;20:301-312.
26. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry. 1989;28:873-881.
27. Cunningham CE, Siegel LS, Offord DR. A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems. J Child Psychol Psychiatry. 1991;32:439-452.
28. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelti L. Methylphenidate in aggressive-hyperactive boys, I: effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry. 1990;29:710-718.
29. Hinshaw SP, Henker B, Whaten CK, Erhardt D, Dunington RE Jr. Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings. J Consult Clin Psychol. 1989;87:636-643.
30. Kaplan SL, Busner J, Kupietz S, Wassermann E, Segal B. Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report. J Am Acad Child Adolesc Psychiatry. 1990;29:719-723.
31. Klorman R, Brumaghim JT, Salzman LF, Strauss J, Borgstedt AD, McBride MC, Loeb S. Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol. 1988;97: 413-422.
32. Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD, Strauss J. Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age. J Abnorm Psychol. 1994; 103:206-221.
33. Murphy DA, Pelham WE, Lang AR. Aggression in boys with attention deficit- hyperactivity disorder: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing. J Abnorm Child Psychol. 1992;20:451-466.
34. Stewart JT, Myers WC, Burket RC, Lyles WB. A review of the pharmacotherapy of aggression in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1990;29:269-277.
35. Klein DF, Gittelman R, Qurtkin F, Rifkin A. Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore, Md: Williams & Wilkins; 1980.
36. Werry J. Differential diagnosis of attention deficits and conduct disorders. In: Bloomingdale LM, Sergeant JA, eds. Attention Deficit Disorder Criteria, Cognition, Intervention. New York, NY: Pergamon Press; 1988:83-96.
37. Herjanic B, Retch W. Development of a structured psychiatric interview for children: agreement between child and parent on individual symptoms. J Abnorm Child Psychol. 1982;10:307-324.
38. Loney J, Milich R. Hyperactivity. inattention, and aggression in clinical practice. In: Wolraich M, Routh DK, eds. Advances in Developmental and Behavioral Pediatrics. Greenwich, Conn: JAI Press; 1982;3:113-147.
39. Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol. 1978;6:221-236.
40. Wechsler D. Wechsler Intelligence Scale for Children-Revised. New York, NY: Psychological Corp; 1974.
41. Abikoff H, Gittelman R. Hyperactive children treated with stimulants: is cognitive training a useful adjunct? Arch Gen Psychiatry. 1985;42:953-961.
42. Gittelman R, Abikoff H, Pollack E, Klein DF, Katz S, Mattes J. A controlled trial of behavior modification and methylphenidate in hyperactive children. In: Whalen C, Henker B, eds. Hyperactive Children: The Social Ecology of Identification and Treatment New York, NY: Academic Press; 1980:221-243.
43. Quay HC. A dimensional approach to children's behavior disorder: the Revised Behavior Problem Checklist. School Psychol Rev. 1983;12:244-249.
44. Miller LS, Klein RG, Piacentini J, Abikoff H, Shah MR, Samoilov A, Guardino M. The New York Teacher Rating Scale for disruptive and antisocial behavior. J Am Acad Child Adolesc Psychiatry. 1995;34:359-370.
45. Klein RG, Abikoff H, Barkley RA, Campbell M, Leckman JF, Ryan ND, Solanto MV. Whalen CK. Clinical trials in children and adolescents. In: Prien RF, Robinson DS, eds. Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. New York, NY: Raven Press; 1994:501-546.
46. Abikoff H, Gittelman R, Klein DF. A classroom observation code for hyperactive children: a replication of validity. J Consult Clin Psychol 1980;48:555-565.
47. Abikoff H, Gittelman R. Classroom observation code: a modification of the Stony Brook Code. Psychopharmacol Bull. 1985;21:901-909.
48. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP. Ludlow C, Mikkelsen EJ. Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal males. Arch Gen Psychiatry. 1980;37:933-943.
49. Jastak S, Wilkinson GS. Wide Range Achievement Test. New York, NY: Psychological Corp; 1984.
50. Gilmore JV, Gilmore EC. Gilmore Oral Reading Test New York, NY: Harcourt Brace & Jovanovich;1968.
51. McArdle P, O'Brien G, Kolvin I. Hyperactivity: prevalence and relationship with conduct disorder. J Child Adolesc Psycho! Psychiatry. 1995;36:279- 303.
52. Myers JK, Bean LL. A Decade Later: A Follow-up of Social Class and Mental Illness. New York, NY: John Wiley & Sons Inc; 1968.
53. Stewart MA, Cummings C, Singer S, deBlois CS. The overlap between hyperactive and unsocialized aggressive children. J Child Psychol Psychiatry. 1981;22: 35-45.
54. Klein RG, Wender P. The role of methylphenidate in psychiatry. Arch Gen Psychiatry. 1995;52:429-433.
55. Hinshaw SP. On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in child psychopathology. Psychol Bull. 1987;101: 443-463.
56. Miczek KA. The psychopharmacology of aggression. In: Iversen LL, Iversen SD, Snyder SH, eds. Handbook of Psychopharmacology. New York, NY: Plenum Press; 1987;19:183-328.
57. Kazdin AE. Treatment of conduct disorder: progress and directions in psychotherapy research. Dev Psychopathol. 1993;5:277-310.
58. Biederman J, Newcorn J, Sprich SE. Comorbidity of attention deficit hyperactivity disorder (ADHD). Am J Psychiatry. 1991;138:564-577.
59. Farrington DP, Loeber R, Van Kammen WB. Long-term criminal outcomes of hyperactivity-impulsivity-attention deficit and conduct problems in childhood. In: Robins LN, Rutter M. eds. Straight and Devious Pathways From Childhood to Adulthood. New York, NY: Cambride University Press; 1990:62-81.